Analysts Set Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Target Price at $19.33

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $19.33.

Several equities research analysts recently commented on the company. Truist Financial boosted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, March 18th. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Mizuho restated a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Finally, JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Tuesday, January 7th.

Sabra Health Care REIT Stock Up 0.6 %

Sabra Health Care REIT stock opened at $17.26 on Monday. Sabra Health Care REIT has a twelve month low of $13.31 and a twelve month high of $20.03. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The firm has a market cap of $4.11 billion, a PE ratio of 32.57, a P/E/G ratio of 1.97 and a beta of 1.27. The firm’s 50 day moving average price is $16.82 and its two-hundred day moving average price is $17.68.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The business had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. On average, research analysts predict that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.95%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is 226.42%.

Hedge Funds Weigh In On Sabra Health Care REIT

A number of institutional investors have recently made changes to their positions in the business. VSM Wealth Advisory LLC acquired a new stake in Sabra Health Care REIT in the 4th quarter valued at approximately $26,000. Quarry LP bought a new position in Sabra Health Care REIT during the third quarter worth $30,000. Assetmark Inc. raised its stake in Sabra Health Care REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock valued at $45,000 after purchasing an additional 656 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Sabra Health Care REIT in the 3rd quarter valued at $59,000. Finally, GF Fund Management CO. LTD. bought a new stake in Sabra Health Care REIT in the 4th quarter valued at $74,000. 99.40% of the stock is currently owned by institutional investors.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.